Clinical Trial

WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia

Study acronym: WATER III
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Comparative analysis of efficacy and safety of Aquablation (AQUABEAM Robotic System®, PROCEPT BioRobotics, Redwood City, CA, USA) and transurethral laser enucleation as surgical therapy for benign prostatic hyperplasia with large prostates (80-180ml).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-03-15; most recent amendment 2025-02-03.
Status change: Recruiting → Active, Not Recruiting 2025-02-03
Trial Details
NCT Number NCT04801381
Lead Sponsor University of Bonn
Collaborators: PROCEPT BioRobotics
Conditions BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms
Enrollment 202 participants
Start Date 2020-12-16
Primary Completion 2025-01-16 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2025-02-06